ArticleRMD open2024

Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database.

Ryoko Sakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.